| 5 | 1/1 | 返回列表 |
| 查看: 784 | 回復(fù): 4 | ||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | ||
xiaomao225新蟲 (正式寫手)
|
[求助]
第一句怎么翻譯 已有2人參與
|
|
|
這句話怎么翻譯?只翻譯這句即可。TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. 不用翻譯Abstract。 Abstract The aim of this study was to investigate the inhibitory effect of TSU68 [(Z)-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid; SU6668], an inhibitor of vascular endothelial growth factor receptor 2, platelet-derived growth factor receptor beta, and fibroblast growth factor receptor 1 (FGFR1), on colon cancer liver metastasis, and to test the hypothesis that TSU68 modulates the microenvironment in the liver before the formation of metastasis. First, we implanted the highly metastatic human colon cancer TK-4 orthotopically into the cecal walls of nude mice, followed by twice-daily administration of TSU68 (400 mg/kg/d) or vehicle. Five weeks of treatment with TSU68 significantly inhibited liver metastasis compared with the control group (P<0.001). Next, we analyzed the gene expression profile in premetastatic liver using microarrays. Microarray and quantitative reverse transcription-PCR analysis showed that mRNA levels for the chemokine CXCL1 were significantly increased in tumor-bearing mice compared with non-tumor-bearing mice. Moreover, CXCL1 expression was significantly decreased by TSU68 treatment. CXCR2 expression was detected predominantly on tumor cells in orthotopic tumors compared with ectopic tumors. The number of migrating neutrophils in premetastatic liver was significantly decreased in the TSU68-treated group (P<0.001). The amount of interleukin-12 (IL-12) p40 in the portal vein was significantly decreased by TSU68 (P=0.02). Blockade of both CXCR2 and IL-12 p40 with a neutralizing antibody significantly inhibited liver metastasis. These results suggest that the CXCL1/CXCR2 axis is important in cancer metastasis and that TSU68 may modulate the premetastatic niche in the target organ through suppression of the inflammatory response, which might be an alternative mechanism used by antiangiogenic agents. |
新蟲 (正式寫手)
銅蟲 (著名寫手)
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿華中農(nóng)業(yè)071010,總分320求調(diào)劑 +5 | 困困困困坤坤 2026-03-20 | 6/300 |
|
|---|---|---|---|---|
|
[考研] 求調(diào)劑 +6 | 十三加油 2026-03-21 | 6/300 |
|
|
[考研] 尋找調(diào)劑 +4 | 倔強(qiáng)芒? 2026-03-21 | 4/200 |
|
|
[考研] 070300化學(xué)求調(diào)劑 +3 | 苑豆豆 2026-03-20 | 3/150 |
|
|
[考研] 303求調(diào)劑 +5 | 安憶靈 2026-03-22 | 6/300 |
|
|
[考研] 材料與化工(0856)304求B區(qū)調(diào)劑 +3 | 邱gl 2026-03-20 | 7/350 |
|
|
[考研] 0703化學(xué)297求調(diào)劑 +3 | Daisy☆ 2026-03-20 | 3/150 |
|
|
[考研] 336求調(diào)劑 +5 | rmc8866 2026-03-21 | 5/250 |
|
|
[考研] 22 350 本科985求調(diào)劑,求老登收留 +3 | 李軼男003 2026-03-20 | 3/150 |
|
|
[考研] 求調(diào)劑 +3 | 白QF 2026-03-21 | 3/150 |
|
|
[考研] 332求調(diào)劑 +3 | 鳳凰院丁真 2026-03-20 | 3/150 |
|
|
[考研] 一志愿山大07化學(xué) 332分 四六級(jí)已過 本科山東雙非 求調(diào)劑! +3 | 不想理你 2026-03-16 | 3/150 |
|
|
[考研] 295材料求調(diào)劑,一志愿武漢理工085601專碩 +5 | Charlieyq 2026-03-19 | 5/250 |
|
|
[考研] 求調(diào)劑 +3 | eation27 2026-03-20 | 3/150 |
|
|
[考研] 08工學(xué)調(diào)劑 +5 | 用戶573181 2026-03-20 | 5/250 |
|
|
[考研] 281求調(diào)劑(0805) +14 | 煙汐憶海 2026-03-16 | 25/1250 |
|
|
[考研] 286求調(diào)劑 +6 | lemonzzn 2026-03-16 | 10/500 |
|
|
[考博] 26博士申請(qǐng) +3 | 1042136743 2026-03-17 | 3/150 |
|
|
[考研] 275求調(diào)劑 +4 | 太陽花天天開心 2026-03-16 | 4/200 |
|
|
[考研] 333求調(diào)劑 +3 | 文思客 2026-03-16 | 7/350 |
|